Acute ischemic stroke (AIS) is a time-sensitive neurological emergency and it remains to be the most common type of stroke. Rapid neuroimaging is the cornerstone for initiating time-sensitive interventions in the treatment of AIS. Revascularization therapies that were once considered irreversible, including intravenous thrombolysis (IVT) and endovascular treatment (EVT), administered in a timely fashion have revolutionized the treatment of AIS. The indications for these therapies have expanded over the past few years and a lot of advancements are happening every year. IVT is offered to all eligible patients presenting within 3 hours of symptom onset and up to 4.5 hours with additional criteria. EVT with stent retrievers or aspiration devices, once limited to the first 6 hours of stroke onset, is now being offered up to 24 hours with advanced image-guided patient selection, which includes a computed tomography or magnetic resonance perfusion imaging. A protocol-based approach to the management of stroke, beginning from prehospital care reduces the time delay in the initiation of treatment. Providing access to these therapies by creating systems of care, hospital stroke team, and "stroke codes" improves the outcome of patients with AIS.
Introduction
Stroke is the second leading cause of death worldwide next to ischemic heart disease. 1 There are over 13.7 million new strokes each year, and ischemic stroke remains to be the most common type with 9.5 million new cases. 2 There are 67.5 million ischemic stroke survivors worldwide and 2.7 million deaths occur from ischemic stroke. Every year, 51.9 million healthy lives are lost due to ischemic stroke-related death and disability. Most strokes occur in age group greater than 44 years, but stroke is also common in young generation (7% of new ischemic stroke and 10% of survivors are under the age of 44 years). Men and women are more or less equally affected (52% of new cases of stroke occur in men vs. 48% in women). 3, 4 The conventional risk factors for the development of stroke are hypertension, diabetes mellitus, hyperlipidemia, smoking, obesity, and sedentary lifestyle. 5 Great progress has been made in the treatment of ischemic stroke with the evolution of intravenous thrombolysis (IVT) and endovascular treatment (EVT). For these treatments to be effective, they should be initiated early from the time of symptom onset. This is possible only by having systems of care and coordination between the specialties. In a typical large vessel occlusion (LVO) about 1.9 million neurons, 14 million synapses, 12 km of myelinated fibers are lost each minute without revascularization. 6 This signifies "Time is brain" and time lost is brain lost. Delay in initiating emergent revascularization therapies will result in worst outcomes.
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• Balance-Acute or sudden onset of loss of balance or co-ordination • Eye signs-Blurred or unclear vision/double vision/gaze preference • Facial weakness-Facial asymmetry • Arm and/or leg weakness • Speech difficulty/slurring of speech • Time is brain-Time to activate stroke system and stroke clock Stroke is a clinical diagnosis, and rapid neuroimaging, usually a non-contrast computed tomography (NCCT) head is performed to rule out a hemorrhage and to initiate time-sensitive interventions. Ischemic stroke is caused by abrupt and sustained reduction in regional cerebral blood flow (CBF) leading to cell death. Within hours, patients often have a central zone of irreversibly damaged tissue destined to die, known as the infarct core and a surrounding zone of damaged tissue that may recover with abrupt restoration of CBF known as penumbra. Secondary stroke prevention targets a variety of mechanisms, including cardiac embolism, artery to artery thromboembolism, occlusive arterial disease, and small vessel disease that caused acute ischemic stroke (AIS). However, detailed mechanism of AIS is not necessarily relevant to the choice of acute treatment.
Prehospital Management
Stroke centers with trained paramedics can easily recognize a stroke and they play a vital role in the stroke system of care in reducing the time delay to administer therapies. The key information that the paramedical team conveys to the stroke center are the time of onset of symptoms or the time last seen normal (LSN), blood pressure (BP), and capillary blood glucose (CBG). A prehospital checklist would help decide the in-house stroke team to bypass the emergency room (ER). An awake patient with normal breathing pattern and who is hemodynamically stable with stroke symptoms can be taken directly to CT. Various prehospital scales are being used to identify stroke and LVO. Cincinnati prehospital stroke severity scale is evaluated to have high accuracy in identifying transient ischemic stroke (TIA) and also stroke severity. 8, 9 Noorian et al did a comparative analysis of eight prehospital scales including Los Angeles Motor Scale (LAMS) and concluded that the LAMS performed in the field by paramedics showed good sensitivity and specificity in identifying LVO AIS patients among all cerebral ischemia patients. 10 Mobile stroke units have the facility to do CT and transfer the image for interpretation to the stroke team and IVT can be initiated in the ambulance. Currently, there is only one mobile stroke unit in India and in future many such would come if found to be cost-effective.
Though guidelines recommend initiating IVT before transferring to EVT facility, 11 many practitioners favor direct shifting to EVT facility without time delay.
Stroke Team and Stroke Code
Systems of care have been found to impart positive outcomes in time-sensitive emergencies including trauma, acute coronary syndrome, and stroke. 12 Depending on the expertise available in a hospital, a stroke team is formed to provide round the clock stroke services. Such team would typically consist of a physician, nursing practitioner, clinical pharmacist, radiographer, technician, laboratory personal, attending staff, social worker, and a manager or counsellor. 13 Once stroke code gets activated, all team members get together and start evaluating the patient, check eligibility for IVT/EVT, and perform their specific roles.
Emergency Room Assessment and Intervention
Patients can be shifted in an ambulance stretcher (without a need to change to hospital trolley). Time should not be wasted in changing to hospital clothes. Before shifting to radiology, the key things to be optimized (if compromised) are the airway, breathing, and circulation. Oxygen supplementation should be given through a face mask if peripheral capillary oxygen saturation is less than 94%. 14 Most often AIS patients present with hypertension. When the cause for stroke is not clearly known at this stage, it is reasonable to reduce the systolic blood pressure (SBP) to target 185 mm Hg as all the stroke patients except for when they present late (out of window period) require BP control to be eligible for revascularization. 15 Two large bore IV cannulas are to be secured in both arms and a balanced crystalloid infusion initiated at 50 mL per hour in one line, while the other dedicated for IVT. Simultaneously, blood has to be collected for laboratory testing. Hypotension with SBP < 90 mm Hg should be aggressively treated with vasopressors as it is associated with poor outcomes. 16 Time should not be delayed in detailed history or neurological examination. Serious neurological issues such as raised intracranial pressure and herniation and status epilepticus should be quickly recognized and treated. The National Institute of Health Scale (NIHSS) (►Table 1) is a recognized tool to document and communicate the neurological deficit in the setting of AIS. 17 The NIHSS ranges from 0 to 42 points with a score of 0 to 5 points suggesting a mild stroke, 6 to 15 a moderate stroke, and greater than 15 a severe stroke.
Apart from establishing the symptom of onset of stroke, a brief medical history including history of medications, particularly the use of anticoagulants, is important in the decision making for treatment. Detailed laboratory tests should not delay neuroimaging. CBG is essential and CBG < 50 mg/dL has to be corrected with dextrose solution. The platelet count and international normalized ratio should be notified immediately once ready, especially when the patient is on oral anticoagulation. Electrocardiogram, chest X-ray, and ECHO are not warranted unless there is pressing serious coexisting cardiac symptoms.
If the prehospital checklist could be completed and stroke team informed, then ER can be bypassed 18 and patient shifted 
Neuroimaging
Rapid imaging of the brain is the key to initiate IVT. NCCT is quick, possesses high sensitivity and specificity to detect intracranial hemorrhage (ICH), and can be done in critically ill patients without any delay. Stroke is a clinical diagnosis, and a normal NCCT does not rule out an AIS. NCCT can exclude alternate causes for neurological symptoms such as subdural hematoma, brain tumor, or other space occupying lesions. A NCCT of brain with no ICH or SAH usually is enough to decide eligibility for IVT in most cases. 19 NCCT allows differentiation between ischemic stroke and intracerebral hemorrhage, and in the case of an ischemic stroke allows quantification of the extent of early ischemic changes by applying the Alberta Stroke Program Early CT Score (ASPECTS), a 10-point score that subtracts a point for each region of parenchymal hypoattenuation within the anterior circulation. 20, 21 Scan quality, training, and experience affect the reliability of ASPECTS (►Fig. 1). Automated software is now available to calculate ASPECT score. 21 Lower scores are predictive of a poor functional outcome with an increased risk of intraparenchymal hemorrhage associated with thrombolysis. 22, 23 A normal looking CT brain implies that infarct has not set in and revascularization in this instance should result in better outcomes. Some of the early signs in CT are hypoattenuating brain tissue, obscuration of lentiform nucleus, dense MCA sign (implying LVO of ICA/MCA) (►Fig. 2), insular ribbon sign, and loss of sulcal effacement. Frank hypodensities especially involving large area may be an established infarct and generally they are excluded from revascularization therapies.
IVT is usually initiated immediately after NCCT in the CT room. Once IVT is initiated for eligible patients after NCCT, a CT angiogram is performed for all patients. 24 Patients with an LVO and eligible for EVT with LSN less than 6 hours are transferred to the neurointervention suite for EVT. Patients with LVO and LSN > 6 hours and up to 24 hours will undergo further imaging, either CT perfusion or magnetic resonance imaging (MRI) to check eligibility for EVT. 25 continued
Item
Title Score NIHSS Complete-profound inattention to one or more modalities (does not recognize own hand or orients to only one side of space)
Abbreviation: NIHSS, National Institute of Health Stroke Scale. CT angiography is used to identify proximal vessel occlusions as possible target lesions for EVT and should be a concurrent imaging study for patients with stroke (►Fig. 3).
Neurointerventionalists can plan an endovascular procedure with CT angiography information. 26 MRI diffusion-weighted imaging and fluid-attenuated inversion recovery are more sensitive to detect ischemia/ infarction, but they are time consuming. DWI maps show early ischemic changes within minutes from stroke onset, and a correlating apparent diffusion coefficient map visualizes the extent of cytotoxic edema caused by brain ischemia. 27 MRI is especially useful in detecting minor strokes and differentiating ischemic stroke from mimics in the setting of ischemic lesions of small volume (►Fig. 4), multiple embolic lesions, and in posterior circulation strokes where the skull base creates bony artifacts on NCCT. Logistics and critical nature of illness make CT the preferred modality although MRI has been used as primary modality in some trials and centers to evaluate stroke.
Intensive efforts are underway to develop a practical and reliable way of assessing core and penumbra. With MRI, areas with diffusion-perfusion mismatch (i.e., DWI lesion within a larger area of perfusion-weighted imaging lesion) have been interpreted as penumbral tissue.
Time of flight MR angiography enables a flow-dependent visualization of the brain arteries without the need for a contrast agent. Susceptibility-weighted imaging allows for the detection of intracerebral hemorrhage with high sensitivity, and the detection of cerebral microbleeds not captured by NCCT, which might indicate underlying pathophysiology, such as cerebral amyloid angiopathy, and might be associated with an increased risk of intracranial hemorrhage after IVT. 28 Specific MRI patterns of image acquisition and processing delay treatment initiation. The threshold for when sufficient information is available to make a correct therapeutic decision should be short. The chance of poor outcome with treatment increases, while time passes with each additional test obtained. 29 Many centers incorporate CT perfusion to assess mean transit time (MTT), CBF, cerebral blood volume, and other parameters to gain insight into the proportion and volume of tissue at risk of infarction. Quantitative perfusion thresholds are used to estimate core (tissue that is already irreversibly damaged), penumbra (tissue that is likely to infarct but salvageable with reperfusion and oligemia (tissue that is not threatened but might have reduced blood flow). A severe relative reduction in CBF of < 30% of normal brain indicates irreversible injury in several trials, including late window treatment trials. Automated software now allows timely postprocessing of CT perfusion functional maps that are robust to common artifacts, allowing rapid interpretation by the clinician (►Fig. 5). However, care is required to avoid delaying treatment decisions because of the time taken to acquire, transfer, postprocess, and interpret CT perfusion data. [29] [30] [31] [32] 
Mechanisms and Principles of Acute Ischemic Stroke Therapy
The most effective treatment of AIS is timely reperfusion by either thrombolysis or thrombectomy. Reperfusion improves outcomes by reducing the volume of infarct. As time from initial stroke increases, the penumbra (viable but ischemic tissue) is quickly replaced by infarcted tissue (irreversibly lost brain tissue). 33 Therefore, swift reperfusion preserves not only the penumbra tissue but also reduces the size of the final infarct core, thereby limiting the volume of damaged tissue and reducing disability from stroke.
Intravenous Thrombolysis
The National Institute of Neurological Disorders and Stroke (NINDS) tissue plasminogen activator (tPA) stroke trial is the landmark trial which leads to the licensing of alteplase in 3-hour window period of stroke. 34 Subsequently, ECASS 35 and ATLANTIS-Btrials 36 evaluated the outcome within 6 hours of symptom onset and the post hoc analysis favored the earlier use is associated with improved outcome thus extending the window to 4.5 hours. The benefit of Alteplase in the 3 to 4.5-hour window has been reemphasized by the results of ECASS II trial. 37 Though the largest trial of thrombolysis showed the improved functional outcome of thrombolysis within 6 hours, the benefit was more when treated within 3 hours. The pooled analysis of multiple trials including NINDS and ATLANTIS reported no outcome benefit of using Alteplase more than the 4.5-hour window. 38 The benefit of low dose of alteplase was analyzed specifically in patients on prior antiplatelets, but ENCHANTED trial reported neutral outcome. Further trials are necessary to identify the benefit of low-dose alteplase. 39 Other drugs such as desmoteplase and tenecteplase have also been studied. Studies reported variable outcomes with desmoteplase. Though NORTEST 40 trial did not favor tenecteplase over alteplase, the EXTEND-IA TNK trial showed that tenecteplase had higher incidence of reperfusion and better functional outcome compared to alteplase within the 4.5-hour window. 41 Tenecteplase might be considered as an alternative to alteplase in patients with minor neurological impairment and no major intracranial occlusion.
Thrombolysis within the 3-hour window and 3-to 4.5hour window is initiated as per eligibility criteria (►Table 2). 35 If there are no absolute contraindications (►Table 3), one can proceed with thrombolysis after having considered the relative conditions. Successful management of hypertension (►Table 4) is essential to administer EVT. Uncontrolled hypertension increases the risks of symptomatic ICH (sICH). Any BP > 185/110 mm Hg should be treated aggressively to target < 180/105 mm Hg during and after IVT. Major complications associated with IVT include ICH, systemic hemorrhage, and angioedema, which have to be quickly recognized and treated (►Table 5). 
IVT for Stroke with Unknown Time of Onset
IV alteplase is generally not recommended in ischemic stroke patients, where the time of onset of symptoms is not clear. In a recent WAKE-UP clinical trial, patients with MRI DWI findings of an ischemic lesion without clearly visible FLAIR signal (indicates the onset of stroke to be less than 4.5 hours) are randomized to receive IVT versus placebo, and the authors found favorable functional outcome at 90 days with IVT. 42
Endovascular Treatment
Endovascular treatment (EVT) with newer stent retrievers and aspiration devices has revolutionized the management of major stroke with LVO (►Fig. 6). Clinical trials such as MR CLEAN, 43 EXTEND-IA, 44 ESCAPE, 45 REVASCAT, 46 SWIFT PRIME, 47 THRACE, 48 THERAPY, 49 53 Thrombolysis in cerebral infarction (TICI) scale grading is used to access the success of EVT. TICI ranges from 0 (no reperfusion) to 3 (normal). Procedural success is usually defined as achieving TICI 2b (antegrade partial perfusion of half or greater than the downstream ischemic territory) or TICI 3. 54
Direct EVT versus Bridging Therapy in Stroke Patients Eligible for IVT
The advantage of bridging therapy with IV thrombolysis before mechanical thrombectomy (MT) among patients with LVO has been studied. Fischer et al stated that immediate and direct MT (dMT) is equally effective and not inferior to bridging thrombolysis. 55 A subsequent meta-analysis of 13 studies favored bridging thrombolysis over dMT patients. 56 But this study has selection bias as they included both IVT eligible and ineligible patients. Further, in a pooled analysis of two stroke registries that included only patients who were eligible for IV thrombolysis, there was no difference in outcomes between the two groups. But with internal carotid artery occlusion, dMT had lower mortality. 57 To exclude all selection bias, Kamal et al presented meta-analysis distinguishing between studies including dMT patients eligible for IVT and studies including dMT patients ineligible for IVT. Though dMT may offer comparable safety and efficacy as compared with IVT + MT, the results varied with less comparable groups. 58 SWIFT DIRECT and MR CLEAN NO IV are the two RCTs in process and these studies will throw up some light on the debate on bridging therapy. We should always analyze for favorable factors, and the decision should be individualized.
Bail Out Stents following Failed Anterior Circulation Thrombectomy
Successful recanalization of emerging LVO is associated with favorable outcome. However, there is recanalization failure and 14 to 41% technical failure rate using stent retriever, balloon guide catheter, or a combination of techniques. 59 Studies showed good safety and recanalization rates with stent placement. Stent deployment maintains vessel patency and improves outcome but necessitates antiplatelet therapy and risk of sICH. Wareham et al in their analysis reported the rate of successful recanalization as 71% and favorable outcome in 43% of the patients. 60 But the studies included were mostly retrospective and heterogenous. However, use of self-expandable stents as a bailout procedure appears to be a reasonable approach.
Anesthesia for Endovascular Treatment
Technique of anesthesia for EVT depends on multiple patient factors. Previously, a meta-analysis of nine retrospective studies suggested that general anesthesia was associated with worse functional outcomes and higher mortality rates. 61 Recently, four prospective randomized controlled trials (RCTs) (GOLIATH, 62 AnStoke, 63 SIESTA, 64 and EAST 65 ) compared the use of general anesthesia versus conscious sedation for endovascular stroke treatment. They did not demonstrate any difference in neurological outcomes between the anesthesia types and found no delay in time to reperfusion in the general anesthesia group. Conscious sedation was associated with worse angiographic quality and more frequent patient movement, whereas general anesthesia was associated with higher rate of successful reperfusion. Hypotension during EVT was an independent predictor for poor neurological outcome. Hence, regardless of anesthesia technique, a strict protocol for aggressive management of intraprocedural systemic BP should be adopted during endovascular stroke treatment. 66 
TIA and Minor Stroke
The historical epidemiological definition differentiating transient ischemic attacks and ischemic stroke on the basis of the duration of their symptoms (less or more than 24 hours) is now outdated because duration does not accurately predict the pathology. MRI studies have shown that symptom duration greater than 1 hour is strongly associated with irreversible ischemia on diffusion-weighted MRI (DWI) and thus clinically defined transient ischemic attacks might not be transient on a tissue level. A transient ischemic attack is not a pathological entity itself but rather the mildest form on the spectrum of ischemic stroke syndrome presentations. Fischer et al defined minor stroke as patients with NIHSS less than 3 as they had the best short-term and medium-term outcomes. 67 All disabling strokes even though minor should be considered for reperfusion treatments. PRISM trial states that treatment with alteplase versus aspirin did not increase the likelihood of favorable functional outcome at 90 days. But the trial was prematurely terminated; hence, we cannot draw any conclusions. In the SITS-ISTR and GWTG registries, good functional outcomes, mortality, and risk of sICH were the same in mild stroke treated in 0 to 3 and 3 to 4.5 hours. 68 Hence, treatment with IV alteplase may be reasonable in mild stroke presenting in the 3-to 4.5-hour window. 69 Generally, an NIHSS of more than 5 points typically warrants thrombolysis in almost all cases; with NIHSS less than 5, patients' premorbid quality of life and activities of daily living have to be taken into consideration to initiate thrombolysis. However, practice varies, with some clinicians consider thrombolysis for minor stroke as standard of care, while others consider it an unresolved research question. Patients with minor stroke are at risk of subsequent deterioration and disability. 70 Establishing the balance between risk and benefit is the impetus for ongoing RCTs of thrombolysis in minor stroke. 71
Malignant Infarction and Decompressive Craniectomy
Osmotic therapy can beused for patients with clinical deterioration from cerebral swelling associated with cerebral infarction and is considered reasonable. In patients who develop symptoms of obstructive hydrocephalus from a cerebellar stroke, emergency ventriculostomy is a reasonable first step in the surgical management paradigm. 72 Decompressive suboccipital craniectomy with dural expansion should be performed in patients with cerebellar infarction, causing neurological deterioration from brainstem compression despite maximal medical therapy. The outcome after cerebellar infarct can be good after suboccipital craniectomy. 73 Malignant MCA infarction is a devastating event with substantial morbidity and mortality because of cerebral edema and raised intracranial pressure and risk of hemorrhagic transformation. Malignant MCA stroke is indicated by MCA territory stroke of > 50% on CT, perfusion deficit of > 66% on CT, and infarct volume > 82 mL within 6 hours of onset (on MRI). [74] [75] [76] DECIMAL, 77 DESTINY, 78 and HAMLET 79 trials and pooled analysis favored decompressive craniectomy over medical treatment in terms of mortality reduction, but functional outcome was not good. 80 DESTINY II trial investigated in patients of age > 60 years and reported mortality reduction but none of the survivors had good outcome. 81 Hence, decompressive hemicraniectomy can be considered in patients < 60 years of age, within 48 hours of stroke onset although outcomes are still likely to be poor. Decompressive craniectomy is not preferable in malignant MCA stroke patients aged > 60 years, as survivors will be severely disabled.
Adjuvant Therapies Antiplatelets
For those treated with IV alteplase, aspirin administration is generally delayed until 24 hours. 82 CHANCE trial favored dual antiplatelet therapy for minor stroke. 83 POINT trial showed low risk of major ischemic events but a high risk of major hemorrhage in minor ischemic stroke or high-risk TIA who received a combination of clopidogrel and aspirin. 84 Secondary analysis of POINT trial revealed that the risk of major hemorrhage was low and most were extracranial and treatable. Intracranial hemorrhages were rare. 85 It is recommended to give treatment for 21 days beginning within 24 hours and beneficial up to 90 days.
Anticoagulation
A systematic review by the Cochrane collaboration demonstrated that anticoagulation (with UFH, LMWH, heparinoids, oral anticoagulants, or thrombin inhibitors) did not decrease the odds of death or development of dependency from stroke. Although anticoagulants prevented pulmonary embolism, they also increased the risk of hemorrhage, leading to the conclusion that anticoagulation cannot be recommended for the treatment of AIS. 86 
Hypothermia
Though animal studies favor hypothermia as an excellent neuroprotective strategy, its benefit in patients with AIS has not been proven. Most trials including ICTUS 2 87 and COOLIST 88 suggest that induction of hypothermia is associated with an increase in the risk of infection, including pneumonia. COOLIST study reported difficulty with induction and maintenance of hypothermia. They were able to achieve only temperature of 35°C with surface cooling. Further incidence of shivering was also higher with hypothermia.
Neuroprotective Drugs
Disrupted blood flow results in a cascade of molecular events leading to cell death. Energy stores deplete and membrane ion pumps malfunction. Excitatory neurotransmitters are released, and oxygen-free radicals are produced. Molecular mediators of this cascade have been tested as targets for drug therapy in animal models, but none has been successfully reduced to clinical practice. 89 Trials of neuroprotective treatments in AIS have been negative. The FAST-MAG trial (Field Administration of Stroke Therapy-Magnesium) of hyperacute magnesium also reported no difference in outcome when compared with placebo in prehospital setting. 90 Hyperbaric oxygen was also found to be not useful in a recent Cochrane analysis.
Sonothrombolysis
Ultrasound waves can accelerate clot lysis through multiple mechanisms. Guidelines do not recommend the use of sonothrombolysis as an adjuvant therapy with IV thrombolysis, as there are no RCT data to support additional clinical benefit of sonothrombolysis. NOR-SASS trial did not report any significant difference neither in the functional outcome at 90 days nor in the rates of sICH. 91
Dysphagia
Dysphagia, a common (37-78%) complication of acute stroke, is a risk factor for aspiration pneumonia and is associated with higher mortality and worse patient outcomes. 92 It is recommended to screen for dysphagia before the patient begins eating, drinking, or receiving oral medications to identify patients at increased risk of aspiration. Fiberoptic endoscopic evaluation of swallowing, video fluoroscopy are reasonable for those patients suspected of aspiration to verify the presence/absence of aspiration.
Systems of Care
Stroke is a quality initiative with a goal of door to needle time (DTN) in less than 60 minutes in at least 50% of eligible patients. The best practices include 11 care strategies to achieve faster DTN (►Fig. 7): emergency medical services pre-notification to hospitals about stroke patients, hospital-specific stroke protocols, a rapid stroke identification and notification system, a single-call stroke activation system, direct to CT protocol, rapid transportation to imaging, rapid interpretation of imaging, rapid protocols for laboratory testing, pre-mixing of recombinant-tPA (r-tPA) in patients with high likelihood of stroke, a team-based approach, and a prompt feedback system. These strategies reduced DTN from a mean of 74 minutes to 59 minutes. 93 Now stroke phase II trial is ongoing with goal of DTN at least 75% of patients within 60 minutes of arrival and at least 50% of patients within 45 minutes of arrival.
Three features of protocol-pre-notification by ambulances, direct-to-CT imaging, and pre-mixing r-tPA-will help in achieving less DTN
Telestroke
Telestroke permits remote audiovisual connection between a stroke center (the "hub") and multiple community hospitals (the "spokes"). Telemedical consultation with a stroke neurologist remotely can reduce DTN times substantially at small hospitals. 94 Transport to the nearest hospital is faster than to the "hub" hospital, potentially resulting in similar onset-totreatment times. 95
Mobile Stroke Units
Apart from achieving earliest DTN, we should also aim to reduce the delay to hospital arrival. Programs have been developed to bring stroke physicians and r-tPA administration to the field in the form of a mobile stroke ambulance. These ambulances are equipped with a mobile CT scanner and point-of-care laboratory testing. In some programs, a stroke physician travels and some others have installed telemedicine equipment for remote interview and examination by a neurologist. 96, 97 The prospective PHANTOM-S study compared conventional care to prehospital thrombolysis with r-tPA with an in-field emergency-trained vascular neurologist. Significantly more patients received r-tPA, and pre-hospital thrombolysis arm had a remarkably lower median onset-to-intervention time (50 vs. 105 minutes, p < 0.001; PHANTOM-S). 98 Mobile stroke units achieve better times even when compared to telestroke units.
Conclusion
The use of neuroimaging for patient selection and speed of diagnosis and delivery of treatment are the dominant themes of modern ischemic stroke care. Advances in technology have led to models of care to deliver r-tPA in a speedy and efficient manner, whether through pre-hospital triage via telephone, r-tPA administration via telemedicine, or actually administering r-tPA in the ambulance. These innovations have revolutionized AIS care from a disease with no treatments to one with multiple proven options. Fig. 7 Algorithm for the management of acute ischemic stroke. aPTT, activated partial thromboplastin time; ASPECTS, Alberta Stroke Program Early CT Score; BP, blood pressure; CBC, complete blood count; CBG, capillary blood glucose; CTA, computed tomography angiography; CTP, computed tomography perfusion; EVT, endovascular treatment; ICP, intracranial pressure; INR, international normalized ratio; IVT, intravenous thrombolysis; LKW, last known well; LVO, large vessel occlusion; MRI, magnetic resonance imaging; MRP, magnetic resonance perfusion; NCCT, noncontrast computed tomography; NIHSS, National Institutes of Health Stroke Scale.
